David Brainard - 19 Feb 2025 Form 4 Insider Report for EverQuote, Inc. (EVER)

Role
Chief Technology Officer
Signature
/s/ Jon Ayotte, as attorney-in-fact for David Brainard
Issuer symbol
EVER
Transactions as of
19 Feb 2025
Net transactions value
-$113,720
Form type
4
Filing time
21 Feb 2025, 16:30:15 UTC
Previous filing
13 Feb 2025
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVER Class A Common Stock Sale $20,256 -912 -0.58% $22.21 156,783 19 Feb 2025 Direct F1
transaction EVER Class A Common Stock Options Exercise $14,698 +1,562 +1% $9.41 158,345 20 Feb 2025 Direct F2
transaction EVER Class A Common Stock Options Exercise $6,925 +1,250 +0.79% $5.54 159,595 20 Feb 2025 Direct F2
transaction EVER Class A Common Stock Options Exercise $26,940 +3,797 +2.4% $7.10 163,392 20 Feb 2025 Direct F2
transaction EVER Class A Common Stock Sale $142,027 -6,609 -4% $21.49 156,783 20 Feb 2025 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVER Stock Option (right to buy) Options Exercise $0 -1,562 -17% $0.000000 7,813 20 Feb 2025 Class A Common Stock 1,562 $9.41 Direct F2, F4
transaction EVER Stock Option (right to buy) Options Exercise $0 -1,250 -12% $0.000000 8,750 20 Feb 2025 Class A Common Stock 1,250 $5.54 Direct F2, F5
transaction EVER Stock Option (right to buy) Options Exercise $0 -625 -9.1% $0.000000 6,250 20 Feb 2025 Class A Common Stock 625 $7.10 Direct F2, F6
transaction EVER Stock Option (right to buy) Options Exercise $0 -3,172 -33% $0.000000 6,343 20 Feb 2025 Class A Common Stock 3,172 $7.10 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022, and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 15, 2025. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The sale does not represent a discretionary trade by the reporting person.
F2 The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $21.90, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
F4 This option was granted on June 28, 2022. The shares underlying the Stock Option are scheduled to vest quarterly over four years with the first installment scheduled to vest on August 20, 2022.
F5 This option was granted on October 24, 2022. The vesting start date for the shares underlying the option is November 20, 2024 and vesting occurs quarterly over a two-year period from the vesting start date.
F6 This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a four-year period from the vesting start date.
F7 This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a two-year period from the vesting start date.